These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39177335)

  • 1. Uterine fibroids and non-informative cell-free DNA screening results.
    Rolnik DL; Raymond Y; Lee T; Ramkrishna J; da Silva Costa F; Menezes M; Meagher S
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):463-469. PubMed ID: 39177335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of fibroids on cell-free DNA screening accuracy.
    Scott F; Menezes M; Smet ME; Carey K; Hardy T; Fullston T; Rolnik DL; McLennan A
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):114-119. PubMed ID: 34396623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive cell-free DNA prenatal screening for trisomy 21 as part of primary screening strategy in twin pregnancy.
    Claudel N; Barrois M; Vivanti AJ; Rosenblatt J; Salomon LJ; Jouannic JM; Picone O; Carbillon L; Vialard F; Launay E; Tsatsaris V; Curis E; El Khattabi L;
    Ultrasound Obstet Gynecol; 2024 Jun; 63(6):807-814. PubMed ID: 37470702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.
    Galeva S; Gil MM; Konstantinidou L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):804-809. PubMed ID: 30977206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined first-trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT.
    Gadsbøll K; Vogel I; Kristensen SE; Pedersen LH; Hyett J; Petersen OB;
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):470-479. PubMed ID: 38642365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between uterine fibroid number and size and risk of preterm birth.
    Gulersen M; Krantz D; Rochelson B; Berghella V; Blitz MJ
    Am J Obstet Gynecol MFM; 2024 Aug; 6(8):101415. PubMed ID: 38944115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
    Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and no call results: optimal timing of cell-free DNA testing and redraw.
    Hopkins MK; Koelper N; Caldwell S; Dyr B; Dugoff L
    Am J Obstet Gynecol; 2021 Oct; 225(4):417.e1-417.e10. PubMed ID: 33839096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10-14 weeks and meta-analysis.
    Judah H; Gil MM; Syngelaki A; Galeva S; Jani J; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Aug; 58(2):178-189. PubMed ID: 33838069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial.
    Kagan KO; Sroka F; Sonek J; Abele H; Lüthgens K; Schmid M; Wagner P; Brucker S; Wallwiener D; Hoopmann M
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):437-444. PubMed ID: 28925570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
    Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
    Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
    Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.
    McKanna T; Ryan A; Krinshpun S; Kareht S; Marchand K; Grabarits C; Ali M; McElheny A; Gardiner K; LeChien K; Hsu M; Saltzman D; Stosic M; Martin K; Benn P
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):73-79. PubMed ID: 30014528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
    Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort.
    Bevilacqua E; Jani JC; Chaoui R; Suk EA; Palma-Dias R; Ko TM; Warsof S; Stokowski R; Jones KJ; Grati FR; Schmid M
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):597-602. PubMed ID: 34090308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with non-invasive prenatal screening for single-gene disorders.
    Mohan P; Lemoine J; Trotter C; Rakova I; Billings P; Peacock S; Kao CY; Wang Y; Xia F; Eng CM; Benn P
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):33-39. PubMed ID: 34358384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.